Can-Fite BioPharma Ltd. (CANF)
Can-Fite BioPharma Ltd., an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic products. These treatments target a range of conditions including various cancers, inflammatory liver disorders, and erectile dysfunction. Its primary drug candidate, Piclidenoson, has successfully advanced through Phase III clinical trials for psoriasis and completed Phase II trials for COVID-19. Another promising asset, Namodenoson, is currently undergoing Phase III clinical evaluation for hepatocellular carcinoma (a form of liver cancer) and is in a Phase IIb study for non-alcoholic steatohepatitis (NASH). Furthermore, CF602 is in preclinical development, aimed at addressing erectile dysfunction. Beyond its drug pipeline, Can-Fite also commercializes a predictive biomarker blood test kit for A3AR. Strategic partnerships are also key to its operations; a licensing and collaboration agreement with CMS Medical covers the development, manufacturing, and commercialization of both Piclidenoson and Namodenoson. Additionally, the company collaborates with Univo Pharmaceuticals to identify and co-develop cannabis-derived formulations intended for various therapeutic applications, including cancer, inflammatory, autoimmune, and metabolic conditions. Originally incorporated in 1994 as Can-Fite Technologies Ltd., the company adopted its current name, Can-Fite BioPharma Ltd., in January 2001 and is headquartered in Petah Tikva, Israel.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Can-Fite BioPharma Ltd.
Nasdaq bars a compliance period at 1:250
- 1:20Reverse splitJan 5, 202620 shares → 1
- 1:10Reverse splitJan 9, 202310 shares → 1
- 1:15Reverse splitMay 10, 201915 shares → 1
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
| Revenue | $408K | $674K | $743K | $810K | $853K | $763K | $2.03M | $3.82M | $845K | $170K | $165K | $0 | $0 | $0 | $469K | $745K |
| YoY Growth | -39.4% | -9.3% | -8.3% | -5.0% | 11.8% | -62.5% | -46.8% | 352.2% | 398.4% | 2.9% | - | - | - | - | -37.1% | - |
| Cost of Revenue | $24K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $384K | $674K | $743K | $810K | $853K | $763K | $2.03M | $3.82M | $845K | $170K | $165K | $0 | $0 | $0 | $469K | $745K |
| Gross Margin | 94.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | - | - | - | 100.0% | 100.0% |
| Research and Development | $6.75M | $5.76M | $5.98M | $7.76M | $9.85M | $11.95M | $10.98M | $6.08M | $5.27M | $6.08M | $3.86M | $4.16M | $4.42M | $3.52M | $3.41M | $2.82M |
| Selling, General, and Administrative | $3.67M | $3.05M | $2.96M | $3.14M | $3.85M | $2.95M | $3.06M | $3.16M | $2.95M | $2.7M | $2.7M | $2.94M | $4.52M | $2.48M | $1.86M | $1.69M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $31K | $29K | $24K | $32K | $53K | -$0 | -$0 | $0 |
| Total Operating Expenses | $10.41M | $8.8M | $8.94M | $10.91M | $13.7M | $14.9M | $14.04M | $9.23M | $8.22M | $8.8M | $6.58M | $7.13M | $8.99M | $6M | $5.27M | $4.51M |
| Operating Income (EBIT) | -$10.03M | -$8.13M | -$8.2M | -$10.1M | -$12.84M | -$14.14M | -$12.01M | -$5.41M | -$7.38M | -$8.63M | -$6.42M | -$7.13M | -$8.99M | -$5.99M | -$4.78M | -$3.76M |
| Operating Margin | -2456.8% | -1206.2% | -1103.0% | -1246.4% | -1505.5% | -1853.1% | -590.9% | -141.7% | -873.1% | -5093.7% | -3894.6% | - | - | - | -1018.3% | -505.1% |
| Interest Expense | $14K | $14K | $14K | $77K | $18K | $363K | $427K | $1.2M | $1.1M | $27K | $564K | $15K | $16K | $7K | $378K | $7K |
| Interest Income | $286K | $291K | $506K | $222K | $24K | $44K | $72K | $51K | $2.99M | $89K | $1.92M | $12K | $26K | $13K | $439K | $31K |
| Other Income (Expense) | $123K | $250K | $561K | -$77K | $227K | -$304K | -$618K | -$1.15M | $781K | $270K | $1.35M | $840K | $146K | $138K | -$2.63M | $152K |
| Income Before Tax (EBT) | -$9.91M | -$7.88M | -$7.63M | -$10.17M | -$12.62M | -$14.44M | -$12.63M | -$6.57M | -$4.95M | -$6.99M | -$5.06M | -$6.29M | -$8.85M | -$5.86M | -$7.42M | -$3.61M |
| Income Tax Expense | $0 | $0 | $0 | $360K | -$20K | $0 | $427K | $4K | $30K | $29K | $4K | $6K | $3K | $3K | $50K | $66K |
| Net Income | -$9.91M | -$7.88M | -$7.63M | -$10.17M | -$12.6M | -$14.44M | -$12.63M | -$6.57M | -$4.97M | -$6.9M | -$4.8M | -$6.1M | -$8.34M | -$5.57M | -$6.7M | -$3.68M |
| Net Income Margin | -2426.7% | -1169.1% | -1027.5% | -1255.9% | -1476.6% | -1892.9% | -621.3% | -172.0% | -588.2% | -4069.3% | -2912.3% | - | - | - | -1428.5% | -493.5% |
| Supplementary Data | ||||||||||||||||
| EPS | -0.08 | -0.01 | -0.01 | -0.03 | -0.06 | -0.08 | -0.30 | -0.34 | -0.38 | -0.60 | -0.54 | -0.70 | -1.22 | -1.12 | -1.44 | -0.84 |
| Diluted EPS | -0.08 | -0.01 | -0.01 | -0.03 | -0.06 | -0.08 | -0.30 | -0.34 | -0.38 | -0.60 | -0.54 | -0.70 | -1.22 | -1.12 | -1.44 | -0.84 |
| Weighted Average OS | 123.59M | 1.09B | 639.17M | 407.87M | 229.44M | 170.75M | 42.95M | 19.45M | 16.26M | 13.85M | 11.48M | 8.77M | 6.86M | 5.03M | 4.68M | 4.34M |
| EBITDA | -$10M | -$8.12M | -$8.18M | -$10.08M | -$12.83M | -$14.13M | -$11.99M | -$6.13M | -$7.17M | -$8.68M | -$6.4M | -$7.12M | -$9.01M | -$5.98M | -$7.33M | -$3.53M |
| EBITDA Margin | -2450.9% | -1205.2% | -1100.9% | -1244.7% | -1503.9% | -1851.5% | -590.2% | -160.4% | -848.3% | -5119.2% | -3884.6% | - | - | - | -1563.5% | -473.1% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $5.53M | $4.83M | $4.28M | $2.98M | $4.39M | $8.27M | $2.7M | $3.62M | $3.5M | $8.11M | $16.91M | $9.27M | $5.96M | $1.15M | $3.84M |
| Short-Term Investments | $3.01M | $3.06M | $4.64M | $5M | $14.75M | $75K | $64K | $273K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $8.54M | $7.89M | $8.92M | $7.98M | $19.14M | $8.34M | $2.76M | $3.89M | $3.5M | $8.11M | $16.91M | $9.27M | $5.96M | $1.15M | $3.84M |
| Accounts Receivable | $74K | $0 | $0 | $47K | $48K | $18K | $637K | $0 | $0 | $22K | $62K | $0 | $58K | $0 | $98K |
| Inventory | $0 | $0 | $0 | -$39K | -$48K | $0 | -$715K | -$3.97M | -$3.3M | $0 | -$621K | $0 | -$623K | $0 | $1 |
| Other Current Assets | $826K | $1.09M | $78K | $47K | $48K | $0 | $729K | $41K | $0 | $0 | $559K | $808K | $565K | $415K | -$0 |
| Total Current Assets | $9.44M | $8.98M | $9.91M | $9.16M | $20.07M | $9.4M | $7.14M | $7.9M | $6.87M | $10.1M | $17.53M | $10.15M | $6.58M | $1.59M | $4.83M |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $74K | $138K | $81K | $126K | $185K | $123K | $118K | $47K | $46K | $53K | $60K | $34K | $41K | $43K | $73K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $8K | $0 | $0 | $0 | $0 | $915K | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | -$8K | $0 | $0 | $912K | $2K | $5K | $10K | $7K | $7K | $10K | $0 | $0 |
| Total Long-Term Assets | $74K | $138K | $81K | $126K | $185K | $123K | $1.03M | $49K | $966K | $63K | $67K | $41K | $51K | $43K | $73K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $9.51M | $9.12M | $9.99M | $9.28M | $20.25M | $9.52M | $8.17M | $7.95M | $7.83M | $10.17M | $17.6M | $10.19M | $6.63M | $1.64M | $4.9M |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $1.16M | $618K | $427K | $896K | $954K | $561K | $2.16M | $1.07M | $427K | $1.25M | $462K | $263K | $590K | $1.98M | $507K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $405K | $405K | $622K | $783K | $818K | $334K | $469K | $926K | $374K | $322K | $220K | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $298K | $675K | $694K | $492K | $603K | $96K | $165K | $149K | $268K | $669K | $149K | $249K | $317K | -$728K | $298K |
| Total Current Liabilities | $2.73M | $2.05M | $2.02M | $2.5M | $2.73M | $1.27M | $3.27M | $3.12M | $1.8M | $2.5M | $1.78M | $1.48M | $2.14M | $2.32M | $1.35M |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $1.18M | $1.58M | $1.71M | $2.29M | $3.07M | $2.16M | $2.42M | $1.82M | $956K | $1.17M | $933K | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | -$2.29M | -$3.07M | -$2.16M | -$2.42M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $2.29M | $3.07M | $2.16M | $1.57M | $0 | $2.14M | $2.62M | $4.45M | $1.85M | $37K | $18K | $258K |
| Total Long-Term Liabilities | $1.19M | $1.63M | $1.73M | $2.31M | $3.14M | $2.18M | $2.46M | $1.82M | $2.98M | $3.79M | $5.38M | $1.85M | $37K | $18K | $258K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3.92M | $3.68M | $3.75M | $4.81M | $5.87M | $3.45M | $5.73M | $4.94M | $4.78M | $6.29M | $7.16M | $3.33M | $2.18M | $2.34M | $1.61M |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 | $60.65M | $33.04M | $8.22M | $2.63M | $2.39M | $1.83M | $1.8M | $1.4M | $1.16M | $732K | $685K |
| Retained Earnings | -$176.19M | -$166.36M | -$158.48M | -$150.85M | -$140.67M | -$125.47M | -$110.31M | -$100.62M | -$105.66M | -$90.98M | -$82.71M | -$78.11M | -$80.51M | -$67.28M | -$60.85M |
| Comprehensive Income & Other | $1.13M | $1.13M | $1.13M | $1.13M | $1.13M | $1.13M | $1.13M | $6.93M | $6.28M | $5.08M | $4.58M | $4.14M | $4.48M | $4.11M | $3.87M |
| Other Stockholders' Equity | $181.78M | $171.8M | $164.72M | $155.32M | $94.4M | $98.51M | $104.53M | $101M | $106.32M | $93.01M | $91.23M | $83.19M | $83.15M | $65.31M | $62.87M |
| Total Equity | $5.59M | $5.44M | $6.24M | $4.47M | $14.38M | $6.07M | $2.44M | $3.02M | $3.05M | $3.87M | $10.32M | $6.48M | $3.8M | -$1.24M | $2.71M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9K | $129K | $375K | $660K | $535K | $584K |
| Total Liabilities and Equity | $9.51M | $9.12M | $9.99M | $9.28M | $20.25M | $9.52M | $8.17M | $7.95M | $7.83M | $10.16M | $17.47M | $9.81M | $5.97M | $1.1M | $4.32M |
| Supplementary Data | |||||||||||||||
| Total Debt | $71K | $104K | $40K | $62K | $124K | $67K | $75K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$5.46M | -$4.72M | -$4.24M | -$2.92M | -$4.27M | -$8.2M | -$2.62M | -$3.62M | -$3.5M | -$8.11M | -$16.91M | -$9.27M | -$5.96M | -$1.15M | -$3.84M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
| Operating Activities | ||||||||||||||||
| Net Income | -$9.83M | -$7.88M | -$7.63M | -$10.17M | -$12.62M | -$14.44M | -$12.63M | -$6.57M | -$4.98M | -$7.02M | -$5.06M | -$6.3M | -$8.85M | -$5.86M | -$7.47M | -$3.68M |
| Depreciation & Amortization | $24K | $7K | $15K | $14K | $14K | $12K | $14K | $14K | $20K | $18K | $16K | $12K | $17K | $23K | $57K | $79K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | -$94K | $11K | $212K | $0 | $279K | $0 | $0 | $0 | -$153K | -$92K | -$35K | $95K |
| Stock-Based Compensation | $340K | $362K | $261K | $263K | $466K | $355K | $385K | $535K | $195K | $309K | $109K | $212K | $788K | $390K | $84K | $177K |
| Changes in Working Capital: | ||||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $2.73M | $270K | -$853K | -$1.16M | -$1.37M | $255K | -$303K | -$159K | $559K | $0 | -$29K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $1.27M | -$316K | $125K | -$0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $547K | $191K | -$469K | -$58K | $393K | -$1.59M | $1.08M | $644K | -$964K | $592K | $79K | -$658K | -$72K | $747K | $177K | -$110K |
| Other Working Capital | -$111K | -$458K | -$474K | -$1.24M | $2.04M | -$401K | $146K | $1.22M | -$323K | $325K | $1.15M | -$0 | $149K | $0 | -$843K | $0 |
| Total Working Capital Change | $436K | -$267K | -$943K | -$1.3M | $2.43M | $2M | $1.19M | $1.13M | -$2.45M | -$449K | $1.49M | -$962K | -$231K | $1.31M | -$667K | -$138K |
| Other Non-Cash Items | $7K | $141K | -$139K | $396K | -$59K | $1K | -$5K | $733K | -$2.59M | -$1.47M | -$1.09M | -$80K | -$203K | -$117K | $2.53M | -$190K |
| Net Cash from Operating | -$9.02M | -$7.64M | -$8.44M | -$10.8M | -$9.86M | -$12.06M | -$10.83M | -$4.16M | -$9.52M | -$8.93M | -$4.65M | -$7.33M | -$8.63M | -$4.35M | -$5.5M | -$3.65M |
| Investing Activities | ||||||||||||||||
| Capital Expenditures | -$2K | -$5K | -$2K | -$9K | -$11K | -$26K | -$3K | -$33K | -$7K | -$10K | -$45K | -$10K | -$12K | -$5K | -$21K | -$30K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$14.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$23K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $1.5M | $500K | $9.51M | $0 | $0 | -$250K | $0 | -$22K | $0 | $3K | $0 | $2K | $25K | $43K | $0 |
| Net Cash from Investing | -$2K | $1.5M | $498K | $9.5M | -$14.51M | -$26K | -$253K | -$33K | -$30K | -$10K | -$43K | -$10K | -$10K | $20K | $22K | -$30K |
| Financing Activities | ||||||||||||||||
| Debt Repaid | - | - | - | - | - | - | $34K | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $9.72M | $6.71M | $9.14M | $0 | $20.46M | $17.68M | $10.17M | $4.39M | $4.47M | $0 | $12.38M | $11.47M | $13.18M | $1.43M | $4.23M | $3.08M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $34K | $0 | $0 | $0 | $0 | $0 | $37K | $68K | $410K | $303K |
| Net Cash from Financing | $9.72M | $6.71M | $9.14M | $0 | $20.46M | $17.68M | $10.17M | $4.39M | $4.88M | $0 | $12.38M | $11.47M | $13.22M | $1.5M | $4.64M | $3.38M |
| Forex Effect | $4K | -$22K | $98K | -$113K | $34K | -$23K | $2K | -$89K | -$812K | -$115K | -$19K | -$201K | $161K | $60K | $72K | -$118K |
| Net Change in Cash | $703K | $547K | $1.3M | -$1.41M | -$3.88M | $5.57M | -$918K | $110K | -$5.48M | -$9.05M | $7.67M | $3.94M | $4.73M | -$2.77M | -$758K | -$419K |
| Supplementary Data | ||||||||||||||||
| Operating Cash Flow | -$9.02M | -$7.64M | -$8.44M | -$10.8M | -$9.86M | -$12.06M | -$10.83M | -$4.16M | -$9.52M | -$8.93M | -$4.65M | -$7.33M | -$8.63M | -$4.35M | -$5.5M | -$3.65M |
| Capital Expenditure | -$2K | -$5K | -$2K | -$9K | -$11K | -$26K | -$3K | -$33K | -$7K | -$10K | -$45K | -$10K | -$12K | -$5K | -$21K | -$30K |
| Free Cash Flow | -$9.02M | -$7.64M | -$8.44M | -$10.81M | -$9.87M | -$12.09M | -$10.84M | -$4.19M | -$9.53M | -$8.94M | -$4.7M | -$7.34M | -$8.64M | -$4.35M | -$5.52M | -$3.68M |
| Cash at Beginning | $4.82M | $4.28M | $2.98M | $4.39M | $8.27M | $2.7M | $3.62M | $3.5M | $8.98M | $17.16M | $9.25M | $5.33M | $1.23M | $3.91M | $4.6M | $5.35M |
| Cash at End | $5.53M | $4.83M | $4.28M | $2.98M | $4.39M | $8.27M | $2.7M | $3.62M | $3.5M | $8.11M | $16.91M | $9.27M | $5.96M | $1.15M | $3.84M | $4.93M |